• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Chennai , Aug 3

THE Chennai-based Orchid Chemicals & Pharmaceuticals Ltd today announced that it has received the formal approval from the US FDA for its generic Ceftriaxone ANDA (Abbreviated New Drug Application).

The approval has been received for Ceftriaxone for injection, 250 mg, 500 mg, 1gm and 2 gm single-dose vials, 1gm and 2gm piggyback vials and 10 gm/100 ml pharmacy bulk package vials.

"Orchid will distribute its Ceftriaxone generic formulations in the US exclusively through Apotex Corp. Orchid has already shipped the product to the US based on prior FDA clearance and Apotex will start distribution of the products to its customers today," says a company press release.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Safety programme comes to ONGC's aid in managing crisis

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line